Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Young Eun AhnSang Jun SuhHyung Joon YimYeon Seok SeoEileen L YoonTae-Hyung KimYoung-Sun LeeSun Young YimHae Rim KimSeong Hee KangYoung-Kul JungJi Hoon KimJong Eun YeonSoon Ho UmKwan Soo ByunPublished in: Gut and liver (2021)
HAIC-based therapy may be an alternative to sorafenib for advanced HCC with main PVTT by providing longer TTP and a better DCR.